FOR IMMEDIATE RELEASE: August 12, 2016
CONTACT: Jonathan Abbamonte, (540) 660-2733, firstname.lastname@example.org
FRONT ROYAL, VA — A stunning new video from the Population Research Institute (PRI) shows that women using injectable contraceptives like Depo-Provera may have a greater risk of contracting HIV. Several studies have now established a probable link between Depo-Provera (sometimes simply called “Depo”) and HIV transmission. Injectables like Depo are among the most widely used contraceptives in Sub-Saharan Africa.
Despite the risk of HIV transmission, the U.S. Government continues to spend tens of millions of dollars every year to ship these dangerous drugs to areas hard-hit by the HIV epidemic.
“It is unconscionable that USAID, UNFPA, and others continue to ship tens of millions of doses of this dangerous contraceptive every year to Sub-Saharan Africa and other areas suffering from the HIV epidemic,” says PRI President Steven W. Mosher. “Numerous observational studies now have found that Depo-Provera and other similar drugs could place women in harm’s way by vastly increasing the likelihood that they will contract HIV. American taxpayers are forced to shell out millions of dollars every year to fund injectable contraceptives like Depo-Provera in Sub-Saharan Africa. This blatant violation of women’s rights on the dime of American taxpayers must cease,” Mosher said.
To learn more, visit: https://www.pop.org/depo-provera-hiv.
The Population Research Institute (PRI) is non-profit, educational organization dedicated to informing the public and policymakers on issues pertaining to population, demography, and human rights. Over the past 25 years, PRI has been a leader in exposing abuses in population control programs such as China’s former one-child policy and in exposing the myth of overpopulation. Depo-Provera® is a registered trademark of Pharmacia & Upjohn Company.